Document is current
Any future updates will be listed below
-
Authors
Mallett, Sue http://orcid.org/0000-0002-0596-8200
Allen, A. Joy
Graziadio, Sara
Taylor, Stuart A.
Sakai, Naomi S.
Green, Kile
Suklan, Jana
Hyde, Chris
Shinkins, Bethany
Zhelev, Zhivko
Peters, Jaime
Turner, Philip J.
Roberts, Nia W.
di Ruffano, Lavinia Ferrante
Wolff, Robert
Whiting, Penny
Winter, Amanda
Bhatnagar, Gauraang
Nicholson, Brian D.
Halligan, Steve
-
Funding
Funding for this research was provided by:
National Institute of Health Research
UCL/UCLH Biomedical Research Centre
NIHR senior investigator
NIHR Newcastle In Vitro Diagnostics Co-operative
NIHR Leeds In Vitro Diagnostic Co-operative
National Institute for Health Research (NIHR) Community Healthcare MedTech and In Vitro Diagnostics Co-operative at Oxford Health NHS Foundation Trust.
NIHR Academic Clinical Lecturer
National Institute for Health Research
- License Information
-
More Information
Article History
Received: 14 July 2020
Accepted: 8 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: SM, SH, AJA, SG, KG, SAT, BS, JP, PT, PW, JS, LFR, NR, NS, JS, AW, JA, GB, KG, and BN declare no conflicts of interest for the submitted work.CH has advised Attomarker, a spin-out company of the University of Exeter about the conduct of evaluations of its tests for COVID antibodies, but received no payment for this advice and provided it as part of academic duties at the University of Exeter.
